Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
Agenus Gross Profit Margin (Quarterly) : 98.50% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.50% |
| March 31, 2026 | 98.27% |
| December 31, 2025 | 98.25% |
| September 30, 2025 | 87.85% |
| June 30, 2025 | 86.72% |
| March 31, 2025 | 86.12% |
| December 31, 2024 | 87.41% |
| September 30, 2024 | 86.09% |
| June 30, 2024 | 85.21% |
| March 31, 2024 | 87.57% |
| December 31, 2023 | 93.48% |
| September 30, 2023 | 87.02% |
| June 30, 2023 | 87.24% |
| March 31, 2023 | 78.80% |
| December 31, 2022 | 66.24% |
| September 30, 2022 | 91.15% |
| June 30, 2022 | 82.25% |
| March 31, 2022 | 91.51% |
| December 31, 2021 | 87.48% |
| September 30, 2021 | 99.01% |
| June 30, 2021 | 77.73% |
| March 31, 2021 | 75.82% |
| December 31, 2020 | 91.55% |
| September 30, 2020 | 81.38% |
| June 30, 2020 | 91.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 82.71% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 76.88% |
| September 30, 2016 | 74.39% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 92.44% |
| June 30, 2015 | 93.10% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 65.11% |
| September 30, 2014 | 72.52% |
| June 30, 2014 | 89.50% |
| March 31, 2014 | 63.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 46.54% |
| Novavax, Inc. | 77.70% |
| Fate Therapeutics, Inc. | -33.53% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 45.74% |
| Return on Invested Capital | 133.5% |
| Profit Margin (Quarterly) | -1.64% |
| Operating Margin (Quarterly) | 32.72% |
| Return on Net Operating Assets | 94.95% |